Anhui Anke Biotechnology (Group) Co Ltd (300009):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anhui Anke Biotechnology (Group) Co Ltd (300009) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7944
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anhui Anke Biotechnology (Group) Co Ltd (Anhui) is a developer, manufacturer and distributor of healthcare and pharmaceutical products. The company’s products include diagnostic products, genetic engineering products, polypeptide APIs, biochemistry products, precision medicine, synthetic medicines, biomedical products, and modern Chinese herb medicines. It also provides series of recombinant human interferon alpha 2b, recombinant human growth hormone, and MAR kit for anti-sperm antibody. AnkeBio’s products are used in the treatment of leukemia, nutritional support, tumor, chronic hepatitis B, burn wounds and immunopurification sterility, among others. The company also conducts research and development for recombinant drugs, pharmaceutical formulation, immunological and traditional Chinese medicines, and chemical medicine. AnkeBio is headquartered in Hefei, China.

Anhui Anke Biotechnology (Group) Co Ltd (300009) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anhui Anke Biotechnology (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Anhui Anke Biotechnology to Form Joint Venture with PersonGen Biomedicine 11
Licensing Agreements 12
Anhui Anke Receives Technology from Lyvgen Biopharma 12
Equity Offering 13
Anhui Anke Biotech Plans to Raise up to USD157 Million in Private Placement of Shares 13
Anhui Anke Biotech Plans to Raise USD16.4 Million in Private Placement 14
Acquisition 15
Anhui Anke Biotechnology to Acquire 30% Stake in Hubei-Based Bio-Tech Firm for USD22.64 Million 15
Anhui Anke Biotech to Acquire 30% Stake in Biotechnology Company for USD15.6 Million 16
Anhui Anke Biotech Plans to Sell its Zhejiang-Based Pharma Unit for USD2.7 Million 17
Anhui Anke Biotech Acquires Wuxi German Midland Biotech for USD73 Million 18
Anhui Anke Biotech Plans to Acquire Shanghai Soho-yiming Pharma for USD65.7 Million 19
Anhui Anke Biotechnology (Group) Co Ltd – Key Competitors 20
Anhui Anke Biotechnology (Group) Co Ltd – Key Employees 21
Anhui Anke Biotechnology (Group) Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anhui Anke Biotechnology (Group) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Anhui Anke Biotechnology (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Anhui Anke Biotechnology to Form Joint Venture with PersonGen Biomedicine 11
Anhui Anke Receives Technology from Lyvgen Biopharma 12
Anhui Anke Biotech Plans to Raise up to USD157 Million in Private Placement of Shares 13
Anhui Anke Biotech Plans to Raise USD16.4 Million in Private Placement 14
Anhui Anke Biotechnology to Acquire 30% Stake in Hubei-Based Bio-Tech Firm for USD22.64 Million 15
Anhui Anke Biotech to Acquire 30% Stake in Biotechnology Company for USD15.6 Million 16
Anhui Anke Biotech Plans to Sell its Zhejiang-Based Pharma Unit for USD2.7 Million 17
Anhui Anke Biotech Acquires Wuxi German Midland Biotech for USD73 Million 18
Anhui Anke Biotech Plans to Acquire Shanghai Soho-yiming Pharma for USD65.7 Million 19
Anhui Anke Biotechnology (Group) Co Ltd, Key Competitors 20
Anhui Anke Biotechnology (Group) Co Ltd, Key Employees 21
Anhui Anke Biotechnology (Group) Co Ltd, Subsidiaries 22
Anhui Anke Biotechnology (Group) Co Ltd, Joint Venture 22

List of Figures
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anhui Anke Biotechnology (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Anhui Anke Biotechnology (Group) Co Ltd (300009):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Owens-Illinois, Inc.
    Owens-Illinois, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens-Illinois, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Episurf Medical AB (EPIS B):企業の製品パイプライン分析
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. It offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer …
  • Dhamma Energy:電力:M&Aディール及び事業提携情報
    Summary Dhamma Energy (Dhamma) is an energy services company that develops, operates and invests in solar photovoltaic installations. The company's services cover the technical and financial studies, development and acquisition, construction and commissioning, and operation and maintenance stages of …
  • Bush Industries Inc
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Valaris Plc (VAL):企業の財務・戦略的SWOT分析
    Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Regal Hotels International Holdings Ltd:企業の戦略・SWOT・財務情報
    Regal Hotels International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Regal Hotels International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Hochdorf Holding AG (HOCN):企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Kallpa Generacion SA:発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Ework Group AB (EWRK):企業の財務・戦略的SWOT分析
    Ework Group AB (EWRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Andrade Gutierrez SA:企業の戦略的SWOT分析
    Andrade Gutierrez SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Wellcome Trust Sanger Institute-製薬・医療分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • H. Lundbeck A/S:企業のM&A・事業提携・投資動向
    H. Lundbeck A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's H. Lundbeck A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Shanghai Pudong Development Bank Co., Ltd.:戦略・SWOT・企業財務分析
    Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • MaxCyte Inc (MXCT):企業の財務・戦略的SWOT分析
    Summary MaxCyte Inc (MaxCyte) is a biotherapeutic company that conducts research and develops cell transfection technologies. The company offers MaxCyte STX, MaxCyte VLX and MaxCyte GT instruments. It utilizes flow electroporation technology for discovery, development and manufacturing of cell-based …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆